세계의 바이오프로세스 최적화 및 디지털 바이오매뉴팩처링 시장

The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.

The North American bioprocess optimization and digital biomanufacturing market is expected to grow from $9.0 billion in 2024 and is projected to reach $14.5 billion by the end of 2029, at a CAGR of 10.0% during the forecast period of 2024 to 2029.

The European bioprocess optimization and digital biomanufacturing market is expected to grow from $7.2 billion in 2024 and is projected to reach $11.5 billion by the end of 2029, at a CAGR of 9.7% during the forecast period of 2024 to 2029.

Report Scope

The report provides a comprehensive analysis of the bioprocess optimization and digital biomanufacturing market in a global context, including market forecasts and sales through the year 2029. Segmentation based on technology type includes manufacturing technologies (chromatography-based separation and purification, filtration, bioreactors, centrifugation), analytical and process control technologies (spectrophotometry, automation and industrial process control technologies, analytical chromatography, sensors and probes), and software (Industrial control and automation software, bioprocess optimization and data analytics software). Segmentation based on application includes biomanufacturing process automation and control, flexible manufacturing, bioprocess optimization and process analytics, and others. By molecule type the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins and peptides, and cell and gene therapies. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report discusses the critical issues impacting the adoption of digital biomanufacturing in pharmaceuticals, as well as emerging trends in digital biomanufacturing technologies. It also features new developments and new product launches in the global market. The report provides comprehensive profiles of market players in the industry. The report also covers mergers and acquisitions and any other collaborations or partnerships that occurred during the evaluation period of this report and which are expected to shape the industry.

Report Includes

• 69 data tables and 61 additional tables
• Analyses of trends in the global market for bioprocess optimization and digital bio-manufacturing, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
• Estimates of the market size and revenue growth prospects of the global market, along with a market share analysis by technology, application, drug molecule type and region
• Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Analysis of patents, emerging trends, and new developments
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and ESG scores and practices of leading companies
• Profiles of the market leaders, including Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corp., and Sartorius AG.

Table of Contents

Chapter 1 Introduction

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background
• Biologics Manufacturing Process
• Upstream Processing
• Cell Harvesting and Clarification
• Downstream Processing
• Bioprocess Optimization
• Industry 4.0-Digital Biomanufacturing

Chapter 3 Market Dynamics

• Global Market Dynamics
• Market Drivers
• Growing Aging Population
• Increasing Prevalence of Chronic Diseases
• Unprecedented Rise in Demand for Biopharmaceuticals
• Growing Number of Product Launches
• Increasing Number of Contract Manufacturing Organizations (CMOs)
• Market Restraints
• Lack of Skilled Labor
• High Cost of Equipment
• Unharmonized Smart Manufacturing Standards
• Market Opportunities
• Favorable Government Programs
• Advances in Sensor Technology
• Process Analytical Technology Initiatives
• Market Challenges
• Technical Issues and the Threat of Cyberattacks
• Regulatory Landscape
• Good Automation Manufacturing Practices (GAMP)
• Instrumentation, Systems, and Automation (ISA) Society-88 and 95 Standards

Chapter 4 Emerging Technologies and Developments

• Emerging Trends and Technologies
• Continuous Bioprocessing
• Continuous Cell Retention Technologies
• Continuous Chromatography
• Single-Use Technologies

Chapter 5 Market Segmentation Analysis

• Key Market Trends
• Segmentation Breakdown
• Market Analysis by Technology
• Manufacturing Technologies
• Analytical and Process Control Technologies
• Software
• Market Analysis by Application
• Biomanufacturing Process Automation and Control
• Flexible Manufacturing
• Bioprocess Optimization and Process Analytics
• Other Applications
• Market Analysis by Molecule Type
• Monoclonal Antibodies (mAbs)
• Therapeutic Proteins and Peptides
• Vaccines
• Cell and Gene Therapies
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Ranking of Leading Players
• Key Strategies Adopted by Players
• Collaborations and Partnerships
• Expansion
• Acquisitions
• New Product Launches

Chapter 7 Sustainability in the Bioprocess Optimization and Digital Biomanufacturing Market: An ESG Perspective

• Introduction to ESG
• ESG Practices in the Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Companies' ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Information Sources
• References
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• AGILITECH
• BIO-RAD LABORATORIES INC.
• BRUKER
• CLEAN BIOLOGICS
• DANAHER CORP.
• EMERSON ELECTRIC CO.
• EPPENDORF SE
• KORBER AG
• MERCK KGAA
• SARTORIUS AG
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• UNIVERCELLS TECHNOLOGIES
• WATERS CORP.